Journal article

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

Constantine S Tam, Lynne V Abruzzo, Katherine I Lin, Jorge Cortes, Alice Lynn, Michael J Keating, Deborah A Thomas, Sherry Pierce, Hagop Kantarjian, Srdan Verstovsek

BLOOD | AMER SOC HEMATOLOGY | Published : 2009

Abstract

Although cytogenetic abnormalities are important prognostic factors in myeloid malignancies, they are not included in current prognostic scores for primary myelofibrosis (PMF). To determine their relevance in PMF, we retrospectively examined the impact of cytogenetic abnormalities and karyotypic evolution on the outcome of 256 patients. Baseline cytogenetic status impacted significantly on survival: patients with favorable abnormalities (sole deletions in 13q or 20q, or trisomy 9 +/- one other abnormality) had survivals similar to those with normal diploid karyotypes (median, 63 and 46 months, respectively), whereas patients with unfavorable abnormalities (rearrangement of chromosome 5 or 7,..

View full abstract